These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38642696)

  • 1. Implementation of perinatal quality collaborative statewide initiative improves obstetrical opioid use disorder care and outcomes.
    Lee King PA; Lee S; Weiss D; Aaby D; Milan-Alexander T; Borders AEB
    Am J Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38642696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in racial disparities in severe maternal morbidity from hemorrhage in a large-scale quality improvement collaborative.
    Main EK; Chang SC; Dhurjati R; Cape V; Profit J; Gould JB
    Am J Obstet Gynecol; 2020 Jul; 223(1):123.e1-123.e14. PubMed ID: 31978432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing severe maternal morbidity for birthing persons with severe hypertension through a statewide quality improvement initiative.
    Borders A; Keenan-Devlin L; Oh EH; Young D; Grobman W; Lee King P
    Am J Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38697335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study.
    Goodman DJ; Saunders EC; Frew JR; Arsan C; Xie H; Bonasia KL; Flanagan VA; Lord SE; Brunette MF
    Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100489. PubMed ID: 34543754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the Timely Delivery of Antihypertensive Medication for Severe Perinatal Hypertension in Pregnancy and Postpartum.
    Schneider P; Lee King PA; Keenan-Devlin L; Borders AEB
    Am J Perinatol; 2021 Aug; 38(10):983-992. PubMed ID: 33934326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ohio Maternal Safety Quality Improvement Project: initial results of a statewide perinatal hypertension quality improvement initiative implemented during the COVID-19 pandemic.
    Schneider P; Lorenz A; Menegay MC; Afflitto S; Lamb E; Cossler N; Dixon K; Gibson KS; Lannon C; Fuller S; Ford S; Oza-Frank R; Everett R; Lappen JR
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100912. PubMed ID: 37003568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marijuana use in opioid exposed pregnancy increases risk of preterm birth.
    Shah DS; Turner EL; Chroust AJ; Duvall KL; Wood DL; Bailey BA
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8456-8461. PubMed ID: 34582287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
    Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
    Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
    Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
    J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
    Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
    J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
    Schiff DM; Nielsen TC; Hoeppner BB; Terplan M; Hadland SE; Bernson D; Greenfield SF; Bernstein J; Bharel M; Reddy J; Taveras EM; Kelly JF; Wilens TE
    Am J Obstet Gynecol; 2021 Oct; 225(4):424.e1-424.e12. PubMed ID: 33845029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds.
    Kitsantas P; Aljoudi SM; Baker KM; Peppard L; Oh KM
    J Subst Use Addict Treat; 2023 May; 148():208960. PubMed ID: 37102193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of structural racism, pandemic stress, and SARS-CoV-2 infection during pregnancy with adverse birth outcomes.
    Janevic T; Lieb W; Ibroci E; Lynch J; Lieber M; Molenaar NM; Rommel AS; de Witte L; Ohrn S; Carreño JM; Krammer F; Zapata LB; Snead MC; Brody RI; Jessel RH; Sestito S; Adler A; Afzal O; Gigase F; Missall R; Carrión D; Stone J; Bergink V; Dolan SM; Howell EA;
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100649. PubMed ID: 35462058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
    Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
    MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Factors Associated with Naloxone Prescription among Pregnant People Admitted for the Management of Opioid Use Disorder.
    Gonzalez AM; Arlandson ME; Patel A; Premkumar A
    Am J Perinatol; 2024 Apr; 41(5):539-542. PubMed ID: 36351448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group vs traditional prenatal care for improving racial equity in preterm birth and low birthweight: the Centering and Racial Disparities randomized clinical trial study.
    Crockett AH; Chen L; Heberlein EC; Britt JL; Covington-Kolb S; Witrick B; Doherty E; Zhang L; Borders A; Keenan-Devlin L; Smart B; Heo M
    Am J Obstet Gynecol; 2022 Dec; 227(6):893.e1-893.e15. PubMed ID: 36113576
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.